Alnylam Pharmaceuticals
ALNY
ALNY
226 hedge funds and large institutions have $6.95B invested in Alnylam Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 76 increasing their positions, 64 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more call options, than puts
Call options by funds: $90.2M | Put options by funds: $81.5M
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
0.29% less ownership
Funds ownership: 95.64% → 95.35% (-0.29%)
Holders
226
Holding in Top 10
8
Calls
$90.2M
Puts
$81.5M
Top Buyers
| 1 | +$199M | |
| 2 | +$65M | |
| 3 | +$60.6M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$58.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$53.2M |
Top Sellers
| 1 | -$69M | |
| 2 | -$26.1M | |
| 3 | -$22.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$18.3M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$17M |